Most bio startups go through periods when they are opaque to the outside world, also known as “stealth mode,” a time of closed, private operations when the company turns inward as it works to achieve its next phase of growth. At some point, however, stealth mode must come to an end. Typically, a company’s first […]

Innate Pharma has an alternative to T cell-based immunotherapy that has the potential to quickly and safely eradicate solid and metastatic tumors in the body. The caveat is that the work has, as yet, advanced only to non-human primates. With IND-enabling studies being conducted by Innate’s partner, Sanofi, the start of human clinical trials seems […]

Cartesian Therapeutics President & Chief Executive Officer, Murat Kalayoglu, MD, PhD, Returns to BioTalk to provide an update since his last visit on their cell and gene therapies, as well as fundraising successes.